Item 8.01. Other Events.
On September 12, 2022, the Company announced the upcoming name and ticker symbol
change via a press release. A copy of the press release is filed herewith as
Exhibit 99.1 and is incorporated by reference in this Item 8.01.
On September 12, 2022, the Company issued a press release entitled "Invivyd
Announces Multiple Next Generation COVID-19 Antibody Candidates and Selects
Combination for Clinical Advancement Based on Positive in vitro Data Against
Omicron Variants." A copy of the press release is filed herewith as Exhibit 99.2
and is incorporated by reference in this Item 8.01.
On September 12, 2022, the Company posted a corporate presentation on its
website at www.Invivyd.com. A copy of the presentation is filed herewith as
Exhibit 99.3 and is incorporated by reference in this Item 8.01.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No. Description
99.1 Press Release, dated September 12, 2022
99.2 Press Release, dated September 12, 2022
99.3 Corporate Presentation, dated September 12, 2022
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses